Press Release: Becton Dickinson Integrates with Accredify to Issue Verifiable COVID-19 Medical Records

Press Release: Becton Dickinson Integrates with Accredify to Issue Verifiable COVID-19 Medical Records

Share this

  • Becton Dickinson (BD) integrates with Accredify to issue verifiable COVID-19 medical records and digitalise COVID-19 workforce screening and management for enterprises
  • The integration follows an increased demand for reliable affordable methods for mass COVID-19 screening and an internal monitoring system to help businesses reopen physical locations efficiently
  • The partnership will benefit businesses in the F&B, hospitality, education, and MICE industry as well as residents who choose to perform ART tests for their personal use

SINGAPORE, 3 November 2021– Becton Dickinson (BD NYSE: BDX), a multinational medical technology firm, today announced its integration with Accredify to issue verifiable results for BD’s COVID-19 antigen rapid test (ART) kits.

The integration follows an increased demand for an automated and affordable methods for mass COVID-19 screening and a robust digitalised employee COVID-19 health management system as businesses attempt to reopen physical locations efficiently.

Through Accredify’s numerous international partnerships, results issued by BD will be recognised by 82 countries and 70 airlines. To date, Accredify has verified digital COVID-19 test results issued by clients and partners around the region more than 7 million times.

Since the beginning of the pandemic, BD has been working very closely with the Singapore government to support their testing strategy and BD ART test has been rolled out to numerous use cases such as border entry, healthcare settings, pre-events testing, etc.

“Antigen testing has gradually become our way of life and our entrance ticket to workplace, schools, events. As employees start to return to work, we understand the challenges that companies face in having to manually track their antigen testing progress and test compliance. As such, we have partnered with Accredify to provide a reliable and simple solution that provides companies with visibility on their employees testing progress, and allow scheduling, reminding, results reporting to the relevant public health authorities as required,” said Shinya Nagase, Vice President of BD Integrated Diagnostics solutions for Central and South Asia, Japan region. “We are excited about the benefits this solution can bring to both employers and employees.”

“The availability of a safe, simple, and reliable self-administered COVID-19 test will provide firms with an efficient employee pre-screening method requiring minimal employer supervision,” said Quah Zheng Wei, CEO and Co-founder, Accredify, “We’re delighted to work with BD to streamline employee COVID-19 testing processes for enterprises around the region.”

BD is also involved in Accredify START, a COVID-19 workforce management system which gives organisations access to COVID-19 testing providers for mass health screening as well as an internal monitoring system application to track their workforce’s COVID-19 health status.

Integrated with SingPass to provide a secure login, individuals taking the test will sign in to Accredify’s START web application which will provide a step-by-step pictorial user guide to self-administer BD’s ART COVID-19 test as well as instructions on how to submit results to employers, event organisers, or relevant management authorities. Individuals can also store and manage previously submitted test results within the application on their mobile devices.  

After an individual submits their results, Accredify will issue a verifiable digital COVID-19 test result to the individual which they can share with respective authorities for verification via a QR code scan on-site or by submitting the test result to the relevant management teams through the START app.

Through Accredify START’s Corporate Dashboard, human resource teams can check if individuals have any overdue COVID-19 test result submissions as well as filter individuals’ swab results by status. Human resource teams can also customise the schedule of email reminders to notify employees of their next ART test due date.

The partnership will benefit businesses in the F&B, hospitality, education, and MICE industry as well as residents who choose to perform ART tests for their personal use.

For more information about Accredify, please contact

For more information about BD’s COVID-19 ART test kits, please contact


Please find screengrabs of Accredify START here

About Accredify

Headquartered in Singapore, Accredify is the leading service provider for organisations to create and issue verifiable documents. With a presence in more than nine markets serving 900 clients globally, documents issued by Accredify have been verified more than 7 million times. With a dedicated team that embraces the highest standards of customer service, security, and privacy, Accredify’s objective is to be the trusted solution for managing and verifying documents anywhere and anytime.

For more information, visit and follow us on LinkedIn @Accredify

About Becton Dickinson

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at and Twitter @BDandCo.

Media Contact

Jessica Tan Shu En

Marketing and Communications Lead, Accredify

Becton Dickinson Media Contact

Nicole Mercado

Communications Executive, Greater Asia